[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
STRAIN=ATCC 25618 / H37Rv;
PubMed=8284673 [NCBI, ExPASy, EBI, Israel, Japan]
Banerjee A.,
Dubnau E.,
Quemard A.,
Balasubramanian V.,
Um K.S.,
Wilson T.,
Collins D.,
de Lisle G.,
Jacobs W.R. Jr.;
"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.";
Science 263:227-230(1994).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=ATCC 25618 / H37Rv;
DOI=10.1038/31159; PubMed=9634230 [NCBI, ExPASy, EBI, Israel, Japan]
Cole S.T.,
Brosch R.,
Parkhill J.,
Garnier T.,
Churcher C.M.,
Harris D.E.,
Gordon S.V.,
Eiglmeier K.,
Gas S.,
Barry C.E. III,
Tekaia F.,
Badcock K.,
Basham D.,
Brown D.,
Chillingworth T.,
Connor R.,
Davies R.M.,
Devlin K.,
Feltwell T., ![]()
Gentles S.,
Hamlin N.,
Holroyd S.,
Hornsby T.,
Jagels K.,
Krogh A.,
McLean J.,
Moule S.,
Murphy L.D.,
Oliver S.,
Osborne J.,
Quail M.A.,
Rajandream M.A.,
Rogers J.,
Rutter S.,
Seeger K.,
Skelton S.,
Squares S.,
Squares R.,
Sulston J.E.,
Taylor K.,
Whitehead S.,
Barrell B.G.;
"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.";
Nature 393:537-544(1998).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=CDC 1551 / Oshkosh;
DOI=10.1128/JB.184.19.5479-5490.2002; PubMed=12218036 [NCBI, ExPASy, EBI, Israel, Japan]
Fleischmann R.D.,
Alland D.,
Eisen J.A.,
Carpenter L.,
White O.,
Peterson J.D.,
DeBoy R.T.,
Dodson R.J.,
Gwinn M.L.,
Haft D.H.,
Hickey E.K.,
Kolonay J.F.,
Nelson W.C.,
Umayam L.A.,
Ermolaeva M.D.,
Salzberg S.L.,
Delcher A.,
Utterback T.R.,
Weidman J.F., ![]()
Khouri H.M.,
Gill J.,
Mikula A.,
Bishai W.,
Jacobs W.R. Jr.,
Venter J.C.,
Fraser C.M.;
"Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.";
J. Bacteriol. 184:5479-5490(2002).
|
[4]
|
X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
PubMed=7886450 [NCBI, ExPASy, EBI, Israel, Japan]
Dessen A.,
Quemard A.,
Blanchard J.S.,
Jacobs W.R. Jr.,
Sacchettini J.C.;
"Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.";
Science 267:1638-1641(1995).
|
[5]
|
X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
DOI=10.1126/science.279.5347.98; PubMed=9417034 [NCBI, ExPASy, EBI, Israel, Japan]
Rozwarski D.A.,
Grant G.A.,
Barton D.H.R.,
Jacobs W.R. Jr.,
Sacchettini J.C.;
"Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.";
Science 279:98-102(1998).
|
[6]
|
X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH NAD AND SUBSTRATE.
DOI=10.1074/jbc.274.22.15582; PubMed=10336454 [NCBI, ExPASy, EBI, Israel, Japan]
Rozwarski D.A.,
Vilcheze C.,
Sugantino M.,
Bittman R.,
Sacchettini J.C.;
"Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.";
J. Biol. Chem. 274:15582-15589(1999).
|
|
ExPASy Home page
APAF Australia